STAT+: Pharmalittle: We’re reading about Congress punts PBM reform, another obesity drug and more
BioMarin Pharmaceutical received a subpoena from the U.S. Department of Justice seeking information about the sponsored testing programs.
by Ed Silverman
Feb 27, 2024
1 minute
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are hovering over the Pharmalot campus again, but our spirits remain sunny, nonetheless. Why? We recall a bit of insight
You’re reading a preview, subscribe to read more.
Start your free 30 days